chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On 03-FEB-2017 at 10:42, the patient was vaccinated with improperly stored VARIVAX injection (lot # M035142) ( expiration date, dose and route of administration were not reported). The vaccine underwent previous temperature excursions. The number of previous excursions, time frames and values of incorrect temperature were unknown. No adverse effects were reported. Digital data logger was used. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1701USA008441:  US-009507513-1704USA000389:  US-009507513-1704USA000390:  US-009507513-1704USA000391:  US-009507513-1704USA000392:  US-009507513-1704USA000393:  US-009507513-1704USA000394:  US-009507513-1704USA000395:  US-009507513-1704USA000396:  US-009507513-1704USA000397:  US-009507513-1704USA000398:  US-009507513-1704USA000399:  US-009507513-1704USA000400:  US-009507513-1704USA000401:  US-009507513-1704USA000402:  US-009507513-1704USA000403:  US-009507513-1704USA000404:  US-009507513-1704USA000405:  US-009507513-1704USA000406:  US-009507513-1704USA000407:  US-009507513-1704USA000408:  US-009507513-1704USA000409:  US-009507513-1704USA000410:  US-009507513-1704USA000411:  US-009507513-1704USA000412:  US-009507513-1704USA000413:  US-009507513-1704USA000414:  US-009507513-1704USA000415:  US-009507513-1704USA000416:  US-009507513-1704USA000458:  US-009507513-1704USA000418:  US-009507513-1704USA000419:  US-009507513-1704USA000420:  US-009507513-1704USA000421:  US-009507513-1704USA000422:  US-009507513-1704USA000423:  US-009507513-1704USA000424:  US-009507513-1704USA000425:  US-009507513-1704USA000426: US-009507513-1704USA000427:  US-009507513-1704USA000428: US-009507513-1704USA000429:  US-009507513-1704USA000430:  US-009507513-1704USA000431:  US-009507513-1704USA000432:  US-009507513-1704USA000433:  US-009507513-1704USA000434:  US-009507513-1704USA000435:  US-009507513-1704USA000436:  US-009507513-1704USA000437:  US-009507513-1704USA000438:  US-009507513-1704USA000439:  US-009507513-1704USA000440:  US-009507513-1704USA000441:  US-009507513-1704USA000442:  US-009507513-1704USA000443:  US-009507513-1704USA000444:  US-009507513-1704USA000445:  US-009507513-1704USA000446:  US-009507513-1704USA000447:  US-009507513-1704USA000448:  US-009507513-1704USA000449:  US-009507513-1704USA000450:  US-009507513-1704USA000451:  US-009507513-1704USA000452:  US-009507513-1704USA000453:  US-009507513-1704U.
I started with the headache the day after the first dose of moderna vaccine. Since then and until today 18 days later it has not been taken away from me and it has been changing. Sometimes they are punctures, sometimes pangs that come and go and sometimes constant pressure. Also my period is 11 days late, which has never happened to me, it is usually early.
Swelling and redness and a hard bump on the arm that has persisted for 1 week. No fever.
Information has been received from a registered nurse concerning a 9 month old female patient who on 07-JUL-2009 was vaccinated with a third 2ml dose of ROTATEQ (663711/0107Y) orally.  No adverse effects were reported.  It was unknown if the patient had sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
EXPIRED VACCINE WAS ADMINISTERED TO PATIENT - EXPIRED ON 5/2/22
None, Moderna Booster Vaccine 0.25ml given from 21st punctured on Vial on 12/2/21 at 10:12pm. No Adverse effects noted at that time.
On October 28, 2011, around 7:00 pm, I went to pharmacy. Where I was given a FLUZONE HIGH DOSE 0.5ml SYR injection. The injection was given in my left arm, several inches above my elbow, which I thought was strange, since all prior injections I've had were always several inches below my shoulder. The first symptom I felt was soreness in my arm. The next day I started to feel flu like symptoms. As the day went on, my body felt ache, hot-chills, nausea, weakness, bouts of diarrhea and throwing-up. In addition, both of my hands from the palms to the tips of my fingers had shooting pains, which felt like lightning strikes. My hands were numb, swollen and I couldn't bend my fingers. By 4:00-5:00 A.M. in the morning I had constant severe pain, in both hands, that would not stop. This went on for hours. I went to hospital, emergency room on 10/30/11. I was given BENADRYL and MOTRIN and was advised to continue their use which I did. After three days I was not much better. So, I went to the county health department, and spoke to RN, BAN, she advised me to notify you of this situation. I then left the county health department and went right to a walk in clinic, and was seen by, ARN. She then prescribed, prednisone 10mg, qty:75. Since, I was still having problems with numbness and pain and heightened sensitivity, in my left hand, I went to see, doctor, who is also a board certified neurologist. He informed me that I should have a blood test and the nerve testing. After all these month I am still having problems.
blood clot in her leg; blood clot in her leg; Cardiac arrest; Heart attack; This is a spontaneous report from a contactable consumer (patient's daughter). A 96-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration on 29Jan2021 (Lot Number: EL9265) as SINGLE DOSE for COVID-19 immunization. Medical history included blood clots in her legs from an unknown date and unknown if ongoing , diabetec, bone infection, surgery and anemic; all from an unknown date and unknown if ongoing; and a family history of gangrene from an unknown date and unknown if ongoing of her mother. Concomitant medications included apixaban (ELIQUIS) taken as blood thinner and furosemide (FUROSEMIDE) taken for an unspecified indication; both start and stop date were not reported. The patient previously had BNT162B2 (Lot Number: EL1283) dose 1 on 08Jan2021 for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was in the military facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 15Mar2021, the patient died due to a heart attack and cardiac arrest. The patient developed a blood clot in her leg and had to have her leg taken off. The date of surgery was 05Feb2021, not early Mar2021 like was originally stated at the hospital. The patient was admitted either on 01Feb2021 or 02Feb2021 and discharged on 23Feb2021. They had a bunch of bad weather and then they put the patient in the nursing facility for about a month and when she was brought home she had a heart attack and died due to cardiac arrest. She doesn't know about the blood clot and this being related to the COVID vaccines but the patient had surgery a week after she had her second shot. The heart attack was on 15Mar2021. The patient had a history of blood clots in her legs before and she had problems with that so that might of made it worse but she doesn't know for sure. The patient died on 15Mar2021.  An autopsy was not performed. The outcome of the event blood clot in her leg was unknown.  No follow-up attempts are possible; information about lot/batch number has been obtained.; Reported Cause(s) of Death: heart attack; cardiac arrest
Patient 1st dose when she was 5 years old never got the 2nd dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 20-year-old female patient who received HAV (Havrix) for prophylaxis.   Previously administered products included Havrix (1st dose received on an unknown date for batch no AHAVB1ZAA).   On an unknown date, the patient did not receive the 2nd dose of Havrix. On an unknown date, unknown after receiving Havrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 13-JUN-2022  Reporter's comment: Health care professional (HCP) reported patient got first dose when she was 5 years old never got the 2nd dose of Havrix.  Patient was now 20 years old, The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up. Additional supportive information: Till the time of reporting, the patient did not receive the 2nd dose of Havrix, which led to incomplete course of vaccination. Note: VARES details pertains to 1st dose of Havrix in product tab.
Information has been received via a company representative, from a physician who after completion of the vaccination of a patient with a prefilled syringe of HPV rL1 6 11 16 18 VLP vaccine (yeast), was pricked in the finger after the syringe "sprung back incorrectly."  Additional information has been requested.
Fainting episode after HPV vaccine given, fall on the floor had bump on forehead/superficial cut inner lip/chipped tooth.
This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 65-year-old female patient who received SHINGRIX for prophylaxis. Co-suspect products included SHINGRIX for prophylaxis. On 22nd August 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, the patient received the 2nd dose of SHINGRIX. On 22nd August 2018, less than a day after receiving SHINGRIX and not applicable after receiving SHINGRIX, the patient experienced injection site erythema. On 23rd August 2018, the patient experienced injection site pain, headache, nausea and fatigue. On an unknown date, the patient experienced drug dose administration interval too long. On 25th August 2018, the outcome of the headache, nausea and fatigue were recovered/resolved. On an unknown date, the outcome of the injection site erythema and injection site pain were recovered/resolved and the outcome of the drug dose administration interval too long was unknown. It was unknown if the reporter considered the injection site erythema, injection site pain, headache, nausea and fatigue to be related to SHINGRIX. Additional details were provided as follows: The injection site became a little red that evening. However, the next day she noticed that the redness was a circle about the size of a small lemon and it was sore. These symptoms lasted for three weeks. At around 9:00 or 10:00 am the next day after receiving the vaccine, the reporter indicated that she had a headache and nausea. These symptoms lasted for two days. Then she felt fatigue which resolved on 25th August 2018, The reporter indicated that she was late to get her second dose of the SHINGRIX vaccine, which led to lengthening of the vaccination schedule. The reporter gave consent to follow up. The reporter given permission for her physician to be contacted.
UNKNOWN WHICH VACCINE BRAND. Presented to the ED with chief complaint of a reported allergic reaction with onset at 0300 this morning. Patient states she woke up feeling like her "airway was closing and her tongue was itching." She reports she received the second dose of the COVID vaccine 2 days ago. Patient took 25 mg of Benadryl upon onset of symptoms, however symptoms persisted. She then took another 25 mg without improvement and decided to come to the ED before her symptoms became worse. Patient states she developed generalized myalgias and nausea after the first COVID vaccine; received diphenhydramine, prednisone, famotidine in ED and for discharge
Pt was in observation room when she stated to me that she felt dizzy and like her heart was "beating fast." She stated it was approx 5-10 minutes after her vaccine was administered. I explained that I would like to extend her observation time to 30 minutes, and perhaps longer if she didn't feel better then. I offered her water and food. She declined water and asked for "a snack." I re-evaluated her approximately every 5 minutes over the next half hour.
TINGLY ON THE RIGHT UPPER LIP; MILDEST ACHY JOINTS; NOT FEELING HUNGRY; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. The patient's past medical history included latent TB, and concurrent conditions included diabetes, obese, and skin eczema, and other pre-existing medical conditions included patient had allergies to MRI dye. The patient was previously treated with immunoglobulin g human; and experienced allergy when treated with metronidazole.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown expiry date: unknown) dose was not reported, administered on 26-MAR-2021 to left arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On MAR-2021, the subject experienced not feeling hungry. On 27-MAR-2021, the subject experienced mildest achy joints. On 28-MAR-2021, the subject experienced tingly on the right upper lip. Laboratory data (dates unspecified) included: Lab test (NR: not provided) negative, 7 times tested. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tingly on the right upper lip, and had not recovered from mildest achy joints, and not feeling hungry. This report was non-serious.      T
Developed Bells Palsy on 4/23 after initial Covid vaccine on 4/9.  Went to Urgent Care on 4/24 and was prescribed Prednisone.  Went to the Neurologist on 4/29.  Had an MRI on 5/6.  No other issues than inflamed facial nerve was found on MRI.  I am on 3 weeks of Bells Palsy and starting to see a very small improvement on the right side of my face which is the side that has been fully paralyzed.
Approx. 1 hour after vaccine, throat became scratchy & developed cough. Cough continued and began to wheeze. Went to ED. Rec'd BENADRYL, SOLU-MEDROL and PEPCID. Discharged to home with PCP follow-up.
Joint Pain-tylenol Fever-tylenol Dizzy spells vertigo-hospitalized and given droperidol iv fluids, meclizine, and valium.  Saw primary care after hospital and given a steroid pack and shot and two weeks later saw a specialist and had my hearing tested.  No known reasons for the issue. nausea
flare of existing autoimmune disease (undifferentiated connective tissue disease (UCTD) with predominant features of systemic sclerosis); flare of existing autoimmune disease (undifferentiated connective tissue disease (UCTD) with predominant features of systemic sclerosis); flare of existing autoimmune disease (undifferentiated connective tissue disease (UCTD) with predominant features of systemic sclerosis); This is a spontaneous report from a contactable physician.  A 35-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EH9899) intramuscular on 22Dec2020 16:15 (04:15 PM) at a single dose on the left arm as COVID-19 vaccine. Medical history included autoimmune disease (undifferentiated connective tissue disease (UCTD) with predominant features of systemic sclerosis); secondary Raynaud's phenomenon with calcinosis; known allergies to sulfa drugs, pine nuts. Concomitant medications included mycophenolate mofetil (MMF) 1000mg bid (twice a day), hydroxychloroquine sulfate (PLAQUENIL) 300mg qd (once a day), and prednisone 15mg daily (received within 2 weeks of vaccination). The patient had an adverse event (AE) of flare of existing autoimmune disease (undifferentiated connective tissue disease (UCTD) with predominant features of systemic sclerosis) on 23Dec2020 09:00 PM (also reported as flare began about 36-48 hours after vaccine) which required increased daily dose of prednisone (higher dose) up to 80mg total daily dose (80mg daily x3d, then tapered down) (treatment received for AE) and lasted about 4-5 days. The patient was not pregnant at the time of vaccination. She had no other vaccine in four weeks (did not receive other vaccine within four weeks prior to the COVID vaccine). She was not diagnosed with COVID-19 prior to vaccination and did not have Covid tested post vaccination (had not been tested for COVID-19 since the vaccination). The patient was vaccinated in a hospital (facility where the most recent COVID-19 vaccine was administered). The outcome of the events was recovered on Dec2020.; Sender's Comments: The Company cannot completely exclude the possible causality between the reported flare of existing autoimmune disease (undifferentiated connective tissue disease (UCTD) with predominant features of systemic sclerosis) and the administration of BNT162B2, based on the plausible temporal association.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to agencys, as appropriate.
Death within 1 hour of event.  My wife called me in the middle of the night - 3:30 am saying "I can't breathe." I rushed to her and asked her whether she could get into the car and when she shook her head no, I called 911.  She kept repeating I can't breathe The paramedics arrived  approx .15 minutes later and took her to Hospital which is nearby.     According to the ER doctor, her heart had stopped beating at the time she reached the hospital.  He asked me whether she had been exposed to COVID and I told him I didn't think so.  She had injured her knee about 3 weeks prior and for a brief period wore a knee brace.  The day prior to her death she said her leg was hurting her but she declined the knee brace when I offered it to her.  She has a family history of blood clots.
Vaccinated 5/27/03. Reaction started 6/8/03. Red raised welps left upper arm, neck, right chest and back. Some raised areas itch. Felt flush at time. Couple episodes of nausea but no vomiting.
pt recvd vax; mom reported that pt felt feverish on 28feb94 am; no t taken; mom also reported infant had difficulty breathing; infant arrested approx 11:30-12pm; cpr attempted but pt pronounced dead; autopsy & cause of death SIDS;
2/5/13 Immunizations received. 2/7/13 Seen for tenderness, ecchymosis (2cm) to left deltoid.
Patient c/o tongue swelling minutes after vaccine. Also c/o itchy throat. No shortness of breath. given IM Benadryl and symptoms resolved. Previous similar reaction to crab.
Received a Flu shot on 10/3 and apparently had a reaction to it at the injection site. My arm was sore which was to be expected but then I noticed swelling/puffiness and redness at the injection site.
Patient/vaccinator unable to state if patient recieved vaccine due to needle retracting and medication(vaccine) oozing from syringe and patient arm
Vaccine given outside of "Beyond Use" date (11/24/22). Given 11/25/22. No treatment needed.
Nausea; Slight temperature 99.7; Fatigue; General feeling of aches and pains; Sore throat; Throat seemed red; Sick; Feeling heavy with her chest. She went to the ER; This is a spontaneous report from a contactable nurse. This nurse reported for a 35-year-old female patient (Daughter) received 2nd dose of BNT162B2 (COVID-19 Vaccine lot number: EK9231, Expiry date: Apr2021) on 16Jan2021 at single dose for covid-19 immunization. Medical history reported was She was positive, our whole family had COVID and we all came down which was about the same time which was 29Dec. Concomitant drug were not reported. Retired Nurse stated, "I am calling for my daughter. She received her 2nd vaccination yesterday morning and she had some side effects. Like about 6 o'clock this morning she came in, she came in 6:35, she came and woke me up and said that she felt some of the reaction she is having. She has nausea, she has slight temperature 99.7, fatigue. Just a general feeling of aches and pains. It does not seem like it's an emergency. She was treated in the ER with steroids and since that point we have all recovered until she went for the 2nd. She works in a hospital, she got her 2nd dose of vaccine like I said yesterday morning. "Retired Nurse stated, "I am not sure causality. I mean it is not an emergency. She was feeling fine yesterday. We all are feeling better now. She had the vaccine and last night she said she had a sore throat when I looked at her throat. Her throat seemed red but there was no angioedema or anything like that, she went to sleep and she came in 'feeling really' (voice distortion) sick. So, I do not know. Did they have relapses from the COVID? I do not know." Treatment was "Tylenol." Like I had said that she was feeling heavy with her chest. She went to the ER. She was at her work. She went to the ER." "Probably close to 10 days ago, they did lab work I think they might have been looking for a clot. They did do some lab work at the hospital with unknown results." Outcome of the event was unknown.  No follow-up attempts possible. No further information expected.
15sec episode of hypotonia, tremors of arm/legs, unresponsive to voice; recurrent w/in 5 mins; pt then slept; sx occurred 9 hr p/DTP #3;
This was my booster (second) J&J vaccine. About five minutes after receiving the vaccine, while I was sitting for the waiting period, I fainted. It began with tunnel vision, cold sweat, and then I blacked out. My wife was with me at the time and was unable to revive me for about ten to fifteen seconds. The pharmacist who gave the injection was also present. After waking up, I was lightheaded and had tingling hands for another ten minutes. After about 20 minutes, I was ok to walk and felt only a little tired. I had this exact same reaction (fainting) when I got my first J&J vaccine in April 2021 (I filed a VAERS report at that time as well - Temporary VAERS E-Report No: 422631).
felt foggy; Exhausted; Sore throat; Upset Stomach; Vomiting; Stomach ache; Indigestion; Body ache; Headache; This case was reported by a consumer via call center representative and described the occurrence of headache in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 6th November 2019, the patient received the 2nd dose of Shingrix. On 7th November 2019, 1 days after receiving Shingrix, the patient experienced headache. On 8th November 2019, the patient experienced sore throat, upset stomach, vomiting, stomach pain, indigestion and general body pain. On 9th November 2019, the patient experienced feeling abnormal and exhaustion. On 10th November 2019, the outcome of the headache and sore throat were recovered/resolved. On an unknown date, the outcome of the upset stomach, vomiting, stomach pain, indigestion, general body pain, feeling abnormal and exhaustion were not recovered/not resolved.   It was unknown if the reporter considered the headache, sore throat, upset stomach, vomiting, stomach pain, indigestion, general body pain, feeling abnormal and exhaustion to be related to Shingrix.  Additional details were provided as follows: On Tuesday, the patient received Shingrix in right arm. On Thursday, she experienced a headache. On Friday, 2 days after Shingrix vaccination, she had a sore throat and headache. On the same night, she experienced upset stomach, stomach ache, vomiting, indigestion and entire body was aching. On Saturday, 3 days after Shingrix vaccination, everything continued and she also felt foggy and exhausted. On Sunday, 10th November 2019, sore throat and headache were gone, but everything else continued. The patient stated, aching still comes and goes. The patient did not consent to follow-up. No further details were provided.